E Bernard
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 16
- Surgery 14
- Orthopedic Infections and Treatments 10
- Infectious Diseases and Tuberculosis 5
- Co-authors
- P. Dellamonica (36 shared papers)R. Garraffo (14 shared papers)Éric Cua (7 shared papers)P Lapalus (6 shared papers)C. Pulcini (7 shared papers)H Drugeon (2 shared papers)V. Mondain (10 shared papers)J. Durant (10 shared papers)
In The Last Decade
E Bernard
51 papers receiving 544 citations
Peers
Comparison fields: 5 of 71
- Applied Microbiology and Biotechnology 41
- Molecular Medicine 85
- Pharmacology 193
- Clinical Biochemistry 63
- Infectious Diseases 159
Countries citing papers authored by E Bernard
This map shows the geographic impact of E Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bernard more than expected).
Fields of papers citing papers by E Bernard
This network shows the impact of papers produced by E Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bernard. The network helps show where E Bernard may publish in the future.
Co-authors
The 25 scholars most cited alongside E Bernard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 66 | |
| 2 | 1989 | 65 | |
| 3 | 2008 | 45 | |
| 4 | 1986 | 45 | |
| 5 | 1989 | 36 | |
| 6 | 2011 | 26 | |
| 7 | 2013 | 22 | |
| 8 | 1990 | 17 | |
| 9 | 2014 | 14 | |
| 10 | 1993 | 14 | |
| 11 | 1994 | 13 | |
| 12 | 1994 | 13 | |
| 13 | [Necrotizing fasciitis of the eyelids and orbit: a life-threatening ophthalmological emergency]. | 2002 | 13 |
| 14 | 2003 | 13 | |
| 15 | Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. | 1992 | 13 |
| 16 | 1997 | 12 | |
| 17 | 1998 | 12 | |
| 18 | 2015 | 12 | |
| 19 | 2012 | 12 | |
| 20 | 2017 | 11 |
About E Bernard
E Bernard is a scholar working on Pharmacology, Surgery, Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 53 papers that have together received 581 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Orthopedic Infections and Treatments (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Streptococcal Infections and Treatments (5 papers), Antibiotic Resistance in Bacteria (5 papers), Infectious Diseases and Tuberculosis (5 papers), Antibiotic Use and Resistance (5 papers) and Infective Endocarditis Diagnosis and Management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (41 citations), Molecular Medicine (85 citations), Pharmacology (193 citations), Clinical Biochemistry (63 citations) and Infectious Diseases (159 citations). E Bernard has collaborated with scholars based in France, Vietnam and Germany. Frequent co-authors include P. Dellamonica, R. Garraffo, Éric Cua, P Lapalus, C. Pulcini, H Drugeon, V. Mondain, J. Durant, Pierre‐Marie Roger and H. Carsenti-Etesse. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Drugs, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.